Complications, risks, and consequences
Estimatedfrequency
Most significant/serious complications
Infection
Subcutaneous/wound
1–5 %
Intrathoracic (pneumonia; pleural; empyema; abscess)
1–5 %
Mediastinitis
0.1–1 %
Osteomyelitis of sternum
1–5 %
Systemic
1–5 %
Bleeding and hematoma formation (intrathoracic; wound; hemothorax)
1–5 %
Reoperation for bleeding (acute <7 days)
1–5 %
Acute graft occlusion
1–5 %
Arrythmias (including AF)
20–50 %
Perioperative myocardial infarction
1–5 %
Cardiac failure
1–5 %
Respiratory failure and prolonged assisted ventilationa
1–5 %
Stroke (cerebrovascular accident)a
1–5 %
Altered psychological state/sleep disturbance/neurocognitive impairment
20–50 %
Graft failure rate (all causes at 10 years)
Internal mammary artery graft
1–5 %
Other vessel grafts
20–50 %
Pulmonary embolism and deep venous thrombosis
1–5 %
Multisystem organ failure (renal, pulmonary, cardiac failure)a
1–5 %
Deatha
1–5 %
Rare significant/serious problems
Pericardial or pleural effusion (late)
0.1–1 %
Persistent air leak/pneumothorax (>48 h)
0.1–1 %
Gastrointestinal complications
0.1–1 %
Right thoracic duct injury (chylous leak, chylothorax, fistula)a
<0.1 %
Diaphragmatic injury/paresis
<0.1 %
Recurrent laryngeal nerve injury
<0.1 %
Esophageal injurya
<0.1 %
Less serious complications
Saphenous vein donor site problemsa
1–5 %
Surgical emphysema
0.1–1 %
Sternal wire protrusion/erosion/pain (median sternotomy)
1–5 %
Rib pain, wound pain (acute <4 weeks)
>80 %
Rib pain, wound pain (chronic >12 weeks)
1–5 %
Wound scarring problems
5–20 %
Deformity of rib/chest or skin (poor cosmesis)
1–5 %
Pleural drain tube(s)a
>80 %
Perspective
See Table 8.1. Coronary artery bypass graft (CABG) surgery in the modern era is routine, although it remains a major invasive procedure. However, the spectrum of cases presenting for coronary surgery becomes evermore complex, older, and with more comorbidities, influencing risk. Coronary arterial disease is a vascular disease, which is a generalized process, and patients presenting for CABG surgery are a high-risk group for multiple other complications. The risk of major complications is largely determined by the severity of the cardiac ischemic insult and comorbidities existing prior to surgery. Early major complications include death, bleeding, cardiac arrythmias, and wound infections. Chest infection is relatively common and is reduced by early mobilization and physiotherapy. Later, debilitating complications include sternal osteomyelitis and chronic pain, which are relatively rare but may be serious. Other major complications include respiratory, renal, and multiorgan failure, which may cause severe disability and prolong hospital stay, and are a significant cause of mortality. Postoperative instability of anticoagulation is relatively common, and bleeding from any site may result, but is rarely severe. Bleeding into the brain or gut may occur and can be catastrophic. Stroke may be embolic or associated with postoperative coagulopathy and is an early cause of mortality or serious permanent disability. Perioperative myocardial infarction may occur, as the underlying problem is coronary arterial insufficiency. The risks of CABG surgery have to be balanced against the risks of not performing the surgery, which may be considerable. CABG surgery is essentially palliative, and redo-CABG surgery is occasionally necessary, due to deterioration of the graft or progressive native coronary arterial disease. Other complications include discomfort, chronic pain, pulmonary embolism, and restenosis. Emergency operations carry higher risk than elective surgery. Carotid endarterectomy may need to precede CABG for high-grade carotid stenosis, to reduce stroke risk. Erosion of sternal wires through skin or dehiscence is alarming for the patient, although a relatively rare problem. Keloid scar formation may be severe, irritating, and unsightly. Insertion of pleural drain tubes is almost uniform.
Major Complications
Stroke, myocardial infarction, pulmonary embolus, pneumonia, intrathoracic bleeding, and severe arrhythmias represent serious complications which are fortunately rare but can be fatal or debilitating. Altered mental function, DVT, infection, chronic pain, anticoagulation instability, reoperation, and sternal osteomyelitis are usually less life-threatening but often severely debilitating complications. Reoperation may be required acutely (<7 days) most often due to bleeding or recurrent ischemia or chronically (>2 months) due to pericardial effusion, both being serious complications associated with increased morbidity and mortality. Multisystem organ failure prolongs ICU care and is the usual prodrome to death associated with complications of CABG, often related to underlying comorbidity. Acute renal failure may require dialysis and is associated with up to 50 % mortality. Respiratory failure may require prolonged mechanical ventilation. Wound infection, sternal osteomyelitis, mediastinitis, and lung infection are uncommon but can be serious complications. Gastrointestinal complications are rare and, when they arise, are often devastating. They may be severe including ulceration, bleeding, bowel ischemia, biliary colic/stasis, pseudo-obstruction/ileus, and pancreatitis. Mortality risk is increased (with or without operation) by existing preoperative conditions, such as diabetes, renal failure, cardiac failure, aortic disease, lung disease, advanced age, and recent smoking history. Significant risk of severe complications may occur without any surgery. Increased use of percutaneous revascularization methods may select out an older more complex population for CABG surgery, which may effectively increase the risk of complications, including mortality.
Consent and Risk Reduction
Main Points to Explain
GA risk
Wound infection
Bleeding
Cardiac arrythmias
Stroke
Respiratory infection
Chest wall pain
Respiratory or renal failure
Further surgery, including reoperation
Death
Aortic Valve Repair or Replacement Surgery
Description
General anesthesia is used. The aim is to replace or repair the malfunctioning aortic valve using a biological tissue or mechanical device or other repair method to re-create unencumbered unidirectional outflow. One of the main aims of cardiac surgery is to avoid the use of anticoagulants and the attendant risks of long-term use of these. Indications for anticoagulation in cardiac surgery include a mechanical prosthesis in any position (aortic, mitral, or tricuspid) or atrial fibrillation. Risks of long-term anticoagulation include thrombosis and embolism from under-anticoagulation and spontaneous bleeding (from brain, gut, and others) from over-anticoagulation. Aortic valve repair is a less commonly used technique and is being developed in a few specialized centers. The approach is typically via a median sternotomy. Extracorporeal cardiac bypass circuits are used. The sternum is usually closed using heavy wires and the skin sutured using subcuticular sutures.
Anatomical Points
The cusps of the aortic valve are usually free but may be fused, either congenitally or acquired. Patients with bicuspid aortic valves also have both an increased incidence of stenosis at a younger age and increased risk of an ascending aortic aneurysm. Other anatomical variants are possible.
Table 8.2
Aortic valve repair or replacement surgery estimated frequency of complications, risks, and consequences
Complications, risks, and consequences | Estimatedfrequency |
---|---|
Most significant/serious complications | |
Infectiona | |
Subcutaneous/wound | 1–5 % |
Intrathoracic (pneumonia; pleural) | 1–5 % |
Pulmonary empyema or abscess | 0.1–1 % |
Mediastinitis | 0.1–1 % |
Osteomyelitis of sternum | 1–5 % |
Systemic | 1–5 % |
Endocarditis (prosthetic valve) | 0.1–1 % |
Bleeding and hematoma formation (overall)a | 1–5 % |
Wound | 0.1–1 % |
Hemothorax | 0.1–1 % |
Pulmonary contusion | 0.1–1 % |
Peri-valvular leakage | 1–5 % |
Pulmonary embolism | 1–5 % |
Difficulty controlling anticoagulationa | 5–20 % |
Arrythmias | 20–50 % |
Conduction system injury/pacemaker requirement | 1–5 % |
Valve failure totala | 5–20 % |
Early (including para-valvular leak) | 1–5 % |
Late (all causes) | 5–20 % |
Hemolysis | 1–5 % |
Valve thrombosis | 1–5 % |
Cardiac failure | 1–5 % |
Perioperative myocardial infarction | 1–5 % |
Stroke (cerebrovascular accident)a | 1–5 % |
Altered psychological state/neurocognitive impairment/sleepdisturbance (>2 months) | 20–50 % |
Reoperation for bleeding (acute <7 days) | 1–5 % |
Reoperation for prosthetic failure, thrombosis, infection (late) | 5–20 % |
Respiratory failurea and prolonged assisted ventilationa | 1–5 % |
Multisystem organ failure (renal, pulmonary, cardiac failure)a | 1–5 % |
Deatha | 1–5 % |
Rare significant/serious problems | |
Persistent air leak/pneumothorax | 0.1–1 % |
Gastrointestinal complications | 0.1–1 % |
Aortic dissection | 0.1–1 % |
Pericardial effusion/tamponade (late) | 0.1–1 % |
Recurrent laryngeal nerve injury | <0.1 % |
Esophageal injurya | <0.1 % |
Diaphragmatic injury/paresis | <0.1 % |
Thoracic duct injury (chylous leak, chylothorax, fistula)a | <0.1 % |
Less serious complications | |
Rib pain, wound pain (acute <4 weeks) | >80 % |
Rib pain, wound pain (acute >12 weeks) | 1–5 % |
Sternal wire protrusion/erosion/pain (median sternotomy) | 1–5 % |
Surgical emphysema | 0.1–1 % |
Wound scarring problems | 5–20 % |
Deformity of rib/chest or skin (poor cosmesis) | 1–5 % |
Pleural drain tube(s)a | >80 % |
Perspective
See Table 8.2. The most common problems associated with cardiac valve surgery are bleeding, cardiac arrhythmias, and chest infection. Infection is relatively rare but may be extremely severe if prosthetic-related endocarditis or sternal osteomyelitis occurs. Anticoagulation difficulties postoperatively are also relatively common, and bleeding may result which may rarely be severe. Bleeding into the brain or gut may occur and can be catastrophic. Perioperative myocardial infarction may occur. Stroke may be a severe and serious problem. Other complications include discomfort, chronic pain, pulmonary embolism, and para-valvular leaks. Keloid scar formation may be severe, irritating, and unsightly. Emergency operations carry higher risk than elective surgery. Carotid endarterectomy may need to precede valve surgery for high-grade carotid stenosis, to reduce stroke risk. Erosion of sternal wires through skin or dehiscence, although a rare problem, is often alarming for the patient.
Major Complications
Stroke, myocardial infarction, pulmonary embolus, pneumonia, valve failure, intrathoracic bleeding, and severe arrhythmias represent serious complications which are fortunately rare but can be fatal. Aortic valve surgery necessarily requires manipulation close to the conduction system, especially in redo surgery, and pacemaker insertion may be required if injury to the conduction system occurs. Altered mental function, DVT, chronic pain, anticoagulation instability, reoperation, and sternal osteomyelitis are usually less life-threatening but often severely debilitating complications. Reoperation may be required acutely (<7 days) most often due to bleeding or chronically (>2 months) due to prosthetic failure; both are serious complications associated with increased morbidity and mortality. Hemolysis can be a severe problem often associated with para-valvular leakage. Multisystem organ failure prolongs ICU care and is the usual prodrome to death associated with complications of valve surgery, often related to underlying morbidity. Renal failure may require dialysis, and pulmonary complications may require prolonged mechanical ventilation. Wound infection, sternal osteomyelitis, mediastinitis, lung infection, and rarely endocarditis are uncommon but can be serious complications. Gastrointestinal complications are rare but may be severe including ulceration, bleeding, bowel ischemia, biliary colic/stasis, pseudo-obstruction/ileus, and pancreatitis. Mortality risk is increased (with or without operation) by existing preoperative comorbidities, such as diabetes, renal failure, cardiac failure, aortic disease, lung disease, advanced age, and recent smoking history. Significant risk of severe complications may occur without any surgery.
Consent and Risk Reduction
Main Points to Explain
GA risk
Wound infection
Bleeding
Cardiac arrythmias
Pacemaker insertion
Stroke
Respiratory infection
Chest wall pain
Respiratory or renal failure
Further surgery, including reoperation
Death
Mitral Valve Repair or Replacement Surgery
Description
General anesthesia is used. The aim is to repair or replace the malfunctioning mitral valve using a variety of repair techniques or a biological tissue or mechanical device, to re-create unidirectional inflow to the ventricle. The approach is typically via a median sternotomy, although minimally invasive techniques are rapidly gaining favor. Mitral stenosis is more commonly rheumatic in origin and the valves are usually replaced, whereas mitral regurgitation has a variety of causes and the valves can usually be repaired. Competence of the mitral valve depends on the mitral annulus, valve leaflets, chordae tendineae, papillary muscles, and the left ventricular wall, so repair of the mitral valve is complex but in the modern era yields predictable results. Valve repair confers better survival figures than prosthetic replacement. One of the main aims of cardiac surgery is to avoid the use of anticoagulants and the attendant risks of long-term use of these. Indications for anticoagulation in cardiac surgery include a mechanical prosthesis in any position (aortic, mitral, or tricuspid) or atrial fibrillation. Risks of long-term anticoagulation include thrombosis and embolism from under-anticoagulation and spontaneous bleeding (from brain, gut, and others) from over-anticoagulation. Extracorporeal cardiac bypass circuits are used to allow entry to the heart. The sternum is usually closed using heavy wires and the skin sutured using subcuticular sutures.
Anatomical Points
The cusps of the mitral valve are usually free but may be fused, either congenitally or acquired. The pathology of the valve will largely determine the surgical technique and functional results.
Table 8.3
Mitral valve repair or replacement surgery estimated frequency of complications, risks, and consequences
Complications, risks, and consequences | Estimatedfrequency |
---|---|
Most significant/serious complications | |
Infection | |
Subcutaneous/wound | 1–5 % |
Intrathoracic (pneumonia; pleural) | 1–5 % |
Osteomyelitis of sternum | 1–5 % |
Mediastinitis | 0.1–1 % |
Systemic | 1–5 % |
Endocarditis (prosthetic valve including late) | 1–5 % |
Peri-valvular leakage (immediate) | 1–5 % |
Valve failure totala | 20–50 % |
Early (including persistent regurgitation after repair) | 1–5 % |
Late (including prosthetic failure) | 20–50 % |
Arrythmias | 20–50 % |
Conduction system injury/pacemaker requirement | 1–5 % |
Bleeding and hematoma formation | 1–5 % |
Difficulty controlling anticoagulation | 5–20 % |
Hemolysis | 1–5 % |
Valve thrombosis | 1–5 % |
Rupture of valve ring (including A-V dehiscence and myocardial rupture) | 1–5 % |
Myocardial injury, cardiac failure, MI (hypotension) | 1–5 % |
Stroke (cerebrovascular accident)a | 1–5 % |
Altered psychological state/neurocognitive impairment, etc. (>2 months) | 20–50 % |
Reoperation (acute <7 days) | 1–5 % |
Reoperation (all causes; late >2 years) | 20–50 % |
Pulmonary embolism | 1–5 % |
Pulmonary failurea | 1–5 % |
Prolonged assisted ventilationa | 1–5 % |
Gastrointestinal complications | 1–5 % |
Multisystem organ failure (renal, pulmonary, cardiac failure)a | 1–5 % |
Deatha | 1–5 % |
Rare significant/serious problems | |
Pulmonary abscess and empyema | 0.1–1 % |
Pericardial effusion/tamponade | 0.1–1 % |
Recurrent laryngeal nerve injury | 0.1–1 % |
Esophageal injurya | 0.1–1 % |
Persistent air leak/pneumothorax/pulmonary injury | 0.1–1 % |
Bronchopleural fistula
Stay updated, free articles. Join our Telegram channelFull access? Get Clinical TreeGet Clinical Tree app for offline access |